When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 46 Hits
  • Search Condition : Filter (MeSH = Antineoplastic Agents / therapeutic use*)
Species Resource
DNA material AxCALacZ Adex1CAlacZ (RDB02726) A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells.
DNA material AxdAdB3-F/RGD (RDB03012). Enhanced antitumor efficacy of integrin-targeted oncolytic adenovirus AxdAdB3-F/RGD on bladder cancer.
General Microbes JCM 1055 , JCM 1057 , JCM 1149 , JCM 1551 , JCM 6651 , JCM 8341 , JCM 8342 , JCM 8344 Anti-tumor activity of heat-killed Lactobacillus plantarum BF-LP284 on Meth-A tumor cells in BALB/c mice.
Mice GFP-LC3#53(RBRC00806) ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice.
DNA material pCMV-MAZ (RDB03219) , pGEX-hMAZ (RDB05701) MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice.
Human and Animal Cells B16/BL6(RCB2638) Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion.
Human and Animal Cells PANC-1(RCB2095) The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
Human and Animal Cells JHOS-2(RCB1521) A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.
Human and Animal Cells colon-26(RCB2657) Potential Antitumor Activity of 2-O-α-d-Glucopyranosyl-6-O-(2-Pentylheptanoyl)-l-Ascorbic Acid.
Human and Animal Cells Colon-26(RCB2657) Lamellarin-inspired potent topoisomerase I inhibitors with the unprecedented benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-one scaffold.
Human and Animal Cells Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells.
Human and Animal Cells Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.
Human and Animal Cells TFK-1 (RCB2537) A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.
Human and Animal Cells TE-5(RCB1949) , TE-8(RCB2098) , TE-10(RCB2099) , TE-1(RCB1894) Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma.
Human and Animal Cells GSU(RCB2278) , H-111-TC(RCB1884) , HGC-27(RCB0500) , MKN7(RCB0999) Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.
Human and Animal Cells CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma.
Human and Animal Cells Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin.
Human and Animal Cells MKN74(RCB1002) Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Human and Animal Cells An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer.
Human and Animal Cells Treatment of central nervous system lymphoma in rats with intraventricular rituximab and serum.